27.02

4.96% -1.415

Amphastar Pharmaceuticals Inc (AMPH)

Overview News Price History Option Chain Financials Why AMPH Down? Discussions Forecast

Amphastar Pharmaceuticals Inc stock is traded at $27.02, with a volume of 412.91K. It is down -4.96% in the last 24 hours and down -19.08% over the past month. Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Previous Close:

$28.43

Open:

$28.51

24h Volume:

412.91K

Relative Volume:

0.75

Market Cap:

$1.36B

Revenue:

$723.55M

Net Income/Loss:

$157.72M

P/E Ratio:

9.005

EPS:

Net Cash Flow:

$170.15M

1W Performance:

-16.32%

1M Performance:

-19.08%

6M Performance:

-42.49%

1Y Performance:

-41.54%

1-Day Range:

$27.01

$29.10

1-Week Range:

$27.02

$32.56

52-Week Range:

$27.02

$53.95

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Name

Amphastar Pharmaceuticals Inc

Sector

Healthcare (1188)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

909-980-9484

Address

11570 SIXTH STREET, RANCHO CUCAMONGA, CA

Employee

1,761

Twitter

Next Earnings Date

2024-12-06

Latest SEC Filings

AMPH's Discussions on Twitter

Compare AMPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AMPH Amphastar Pharmaceuticals Inc	27.02	1.36B	723.55M	157.72M	170.15M	3.00
ZTS Zoetis Inc	169.15	75.15B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.62	47.71B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.98	47.70B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.29	18.75B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.26	13.96B	612.78M	-86.37M	-62.91M	-0.87

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-04-25	Downgrade	Piper Sandler	Overweight → Neutral
Nov-22-24	Initiated	Wells Fargo	Equal Weight
Mar-05-24	Initiated	JP Morgan	Overweight
Nov-17-23	Initiated	BofA Securities	Neutral
Jul-25-23	Resumed	Jefferies	Buy
Oct-21-22	Resumed	Jefferies	Buy
Jul-29-22	Initiated	CapitalOne	Overweight
Jan-07-22	Upgrade	Piper Sandler	Neutral → Overweight
Jan-08-21	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-05-20	Upgrade	Northland Capital	Market Perform → Outperform
May-01-20	Initiated	Northland Capital	Outperform
Mar-13-19	Downgrade	Needham	Buy → Hold
Mar-13-19	Downgrade	Piper Jaffray	Overweight → Neutral
Aug-10-18	Reiterated	Needham	Buy
Mar-13-18	Reiterated	Needham	Buy
Dec-01-17	Reiterated	Needham	Buy
Nov-09-17	Downgrade	Raymond James	Outperform → Mkt Perform
Sep-27-17	Reiterated	Needham	Buy
Mar-14-17	Downgrade	Raymond James	Strong Buy → Outperform
Aug-09-16	Reiterated	Needham	Buy
May-10-16	Reiterated	Needham	Buy
Feb-19-16	Initiated	Wells Fargo	Outperform
Jun-19-15	Reiterated	Needham	Buy
Jun-03-15	Initiated	Raymond James	Strong Buy
Jul-21-14	Initiated	Needham	Buy

View All

Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News

Mar 02, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Earnings Results - MarketBeat

Mar 02, 2025

Amphastar stock hits 52-week low at $30.32 amid market shifts - Investing.com Australia

Mar 02, 2025

D.A. Davidson & CO. Makes New $417,000 Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 02, 2025

Mar 01, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 52-Week LowShould You Sell? - MarketBeat

Mar 01, 2025

17,049 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Acquired by Illumine Investment Management LLC - MarketBeat

Mar 01, 2025

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Mar 01, 2025

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now? - Yahoo Finance

Mar 01, 2025

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference - ACCESS Newswire

Mar 01, 2025

Feb 28, 2025

Allspring Global Investments Holdings LLC Sells 10,199 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Feb 28, 2025

Amphastar’s Earnings Call: Growth Amid Challenges - TipRanks

Feb 28, 2025

Primatene Mist Sales Key To Amphastar Growth - Citeline News & Insights

Feb 28, 2025

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds - AOL

Feb 28, 2025